Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/01/30/2819700/0/en/COUR-Pharmaceuticals-Secures-105-Million-in-Series-A-Financing-Co-Led-by-Lumira-Ventures-and-Alpha-Wave-Ventures.html
https://www.prnewswire.com/news-releases/cour-pharmaceuticals-appoints-dannielle-appelhans-as-chief-operating-officer-301880852.html
https://www.globenewswire.com/news-release/2023/02/08/2603898/0/en/COUR-Pharmaceuticals-Announces-Biotechnology-Industry-Veteran-Robert-F-Carey-Joins-Board-of-Directors-as-Lead-Independent-Director.html
https://www.prnewswire.com/news-releases/cour-pharmaceuticals-boehringer-ingelheim-genentech-gsk-and-idorsia-pharmaceuticals-to-keynote-at-veeva-commercial-summit-europe-301678297.html
https://www.prnewswire.com/news-releases/cour-pharmaceuticals-announces-fda-clearance-of-investigational-new-drug-application-for-myasthenia-gravis-301658843.html
https://www.prnewswire.com/news-releases/cour-pharmaceuticals-appoints-brian-c-bock-as-chief-financial-officer-301491484.html
https://www.prnewswire.com/news-releases/cour-pharmaceuticals-receives-fda-fast-track-designation-for-cnp-104-for-the-treatment-of-primary-biliary-cholangitis-301456793.html
https://www.prnewswire.com/news-releases/cour-pharmaceuticals-announces-first-in-human-dosing-in-proof-of-concept-trial-of-cnp-201-to-treat-peanut-allergy-301403393.html
https://www.prnewswire.com/news-releases/us-fda-accepts-cour-pharmaceuticals-investigational-new-drug-application-ind-for-a-proof-of-concept-study-for-the-treatment-of-primary-biliary-cholangitis-pbc-301391824.html
https://www.prnewswire.com/news-releases/fda-accepts-investigational-new-drug-application-for-peanut-allergy-candidate-developed-by-cour-pharmaceuticals-301378196.html